Joined Today: 31

UGNE Unigene Laboratories, Stock Message Board

All Messages

UGNE Message Board Home | Join The UGNE Group |

#32: Unigene Joint Venture Breaks Ground for Global Biotechnology Park in China
NewsBot	April 23, 2008 08:54:55 AM
Unigene Biotechnology Co. Ltd. Facilities to Perform Research, Development, Formulation and Manufacturing First Phase of Construction to be Completed in 2008, Production and... view message ignore post recommend post

#31: Unigene States That New Government Study Reports That Many Osteoporosis Medications Prevent Fractures, but None is Proven Best
NewsBot	December 19, 2007 10:02:53 AM
Unigene Laboratories, Inc. (OTCBB: UGNE) reports that a comparative analysis of various osteoporosis therapies has been published, concluding that there is insufficient evidence to support claims... view message ignore post recommend post

#30: UGNE News Unigene's Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis
NewsBot	March 20, 2007 05:31:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--The site-directed bone growth (SDBG) technology currently being developed by Unigene Laboratories, Inc. (OTCBB: UGNE) in conjunction with Yale... view message ignore post recommend post

#29: UGNE News Unigene Announces Financial Results for Fourth Quarter and Year-End 2006
NewsBot	March 19, 2007 05:00:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) announced its financial results for December 31, 2006. Revenue for the three months ended December 31,... view message ignore post recommend post

#28: UGNE News Unigene to Release Fourth Quarter and Year-End 2006 Results and Host Conference Call on March 19th
NewsBot	March 13, 2007 10:52:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) will release financial results for the year ended December 31, 2006, before the market opens on Monday, March... view message ignore post recommend post

#27: UGNE News Unigene Achieves $5.5 Million Milestone in Calcitonin Collaboration for Phase III Initiation
NewsBot	February 27, 2007 05:17:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--The initiation of a Phase III clinical study for osteoporosis by Nordic Bioscience, the development partner of Novartis Pharma AG, with oral calcitonin... view message ignore post recommend post

#26: UGNE News Unigene Receives Phase II SBIR Grant for Novel Peptide Discovery Program
NewsBot	February 15, 2007 05:37:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) has been awarded a Phase II Small Business Innovative Research (SBIR) Grant from the National Institute for... view message ignore post recommend post

#25: UGNE News Unigene Engages University Clinicians to Advise on Bone Growth Program
NewsBot	November 30, 2006 05:30:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) has engaged two leading clinicians as consultants to assist in the development and testing relating to the... view message ignore post recommend post

#24: UGNE News Unigene Announces Results for the Third Quarter of 2006
NewsBot	November 9, 2006 01:48:00 PM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) announced its financial results for September 30, 2006. Revenue for the three months ended... view message ignore post recommend post

#23: UGNE News Unigene to Release Third Quarter 2006 Results and Host Conference Call on November 10th
NewsBot	November 8, 2006 05:45:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) will release financial results for the third quarter ended September 30, 2006, before the market opens on... view message ignore post recommend post

#22: UGNE News Unigene to Present at the 8th Annual Rodman and Renshaw Healthcare Conference on November 8th 2006
NewsBot	November 3, 2006 05:30:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc.’s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the 8th Annual Rodman and Renshaw Healthcare... view message ignore post recommend post

#21: UGNE News Unigene to Present at the UBS Global Life Sciences Conference on September 27, 2006
NewsBot	September 19, 2006 05:30:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Sept. 19, 2006--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the 8th Annual UBS Global Life Sciences Conference on... view message ignore post recommend post

#20: UGNE News Unigene to Present at the ThinkEquity Partners Conference; Fortical(R) Sales to Upsher-Smith Resume
NewsBot	August 30, 2006 05:45:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 30, 2006--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the 4th Annual ThinkEquity Partners Conference on... view message ignore post recommend post

#19: UGNE News Unigene Named Ninth Fastest Growing Technology Company in New Jersey in Deloitte's Technology Fast 50 Program
NewsBot	August 11, 2006 04:00:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 11, 2006--Unigene Laboratories, Inc. (OTCBB: UGNE) has been named to Deloitte's prestigious Technology Fast 50 Program for New Jersey. It was ranked ninth out... view message ignore post recommend post

#18: UGNE News Unigene Announces Results for the Second Quarter of 2006
NewsBot	August 10, 2006 04:30:00 AM
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 10, 2006--Unigene Laboratories, Inc. (OTCBB: UGNE) announced its financial results for June 30, 2006. Revenue for the three months ended June 30, 2006 was... view message ignore post recommend post

Group Home | Login if you want to post a message